This review highlights ivabradine as an important therapeutic choice for heart rate reduction and symptom management in patients with stable CAD or chronic HF.
No takes yet. Share an insight, caveat, or question.
May support symptom relief via pure HR reduction in stable CAD/HF; leaves open need for updated outcome trials.
Prakash Deedwania (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: